UNH
UnitedHealth Group Incorporated
UNH has the edge over VNDA overall, supported by lower modeled downside and stronger fundamentals.
VNDA
Vanda Pharmaceuticals Inc.
VNDA's outlook is improving, though it still trails on the overall score.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
VNDA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Strong |
VNDA's revenue and balance sheet are currently healthy, but its profitability and cash flow are weak.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
VNDA PE Valuation
VNDA has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
VNDA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
VNDA has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over VNDA on earnings quality, reporting a profit while its opponent remains loss making.
VNDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.63 | -$3.20 |
| Q2 2026 | -$4.64 | -$3.50 |
| Q1 2026 | -$4.06 | -$3.30 |
| Q4 2025 | -$3.74 | -$3.41 |
| Q3 2025 | -$1.43 | -$1.14 |
| Q2 2025 | -$1.14 | -$0.94 |
| Q1 2025 | -$0.76 | -$0.67 |
| Q4 2024 | -$0.33 | -925% |
VNDA lost $4.63 per share over the past year, a bigger loss than the year before.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over VNDA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over VNDA on profitability, with a higher operating margin.
VNDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $69.8M | +24% |
| Q2 2026 | $50.5M | -3.9% |
| Q1 2026 | $51.7M | +3.4% |
| Q4 2025 | $57.2M | +7.6% |
| Q3 2025 | $56.3M | +18% |
| Q2 2025 | $52.6M | +4.2% |
| Q1 2025 | $50M | +5.4% |
| Q4 2024 | $53.2M | +17% |
VNDA's revenue is growing: $70M last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -34% | +22 points |
| Q2 2026 | -126% | -53 points |
| Q1 2026 | -97% | -15 points |
| Q4 2025 | -71% | -51 points |
| Q3 2025 | -56% | -33 points |
| Q2 2025 | -73% | -53 points |
| Q1 2025 | -82% | -63 points |
| Q4 2024 | -19% | -3.7 points |
VNDA's operating margin was −34% last quarter, up 22 points from the same quarter a year ago.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over VNDA on cash generation, producing positive trailing cash flow while its opponent burns cash.
VNDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$28.7M | +$3M |
| Q2 2026 | -$31.3M | -$15.7M |
| Q1 2026 | -$50.4M | -$16.9M |
| Q4 2025 | -$29.5M | -$27.5M |
| Q3 2025 | -$31.8M | -$17M |
| Q2 2025 | -$15.6M | -$8.5M |
| Q1 2025 | -$33.6M | -544% |
| Q4 2024 | -$2M | +$2M |
VNDA has burned cash in eight of the last eight quarters: −$140M over the past year, against −$83M the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over VNDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
VNDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +239K shares |
| 1 year | +2.3% | +1.4M shares |
| 3 years | +5% | +2.9M shares |
| 5 years | +6% | +3.4M shares |
| Available history | +10% | +5.6M shares |
VNDA has 60M diluted shares, up 2.3% from a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
VNDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2023 | -80.1x | Net Cash |
| Q2 2023 | -12.2x | Net Cash |
| Q1 2023 | -18.9x | Net Cash |
| Q4 2022 | -14.9x | Net Cash |
| Q3 2022 | -4.5x | Net Cash |
| Q2 2022 | -3.2x | Net Cash |
| Q1 2022 | -2.5x | Net Cash |
| Q4 2021 | -1.2x | Net Cash |
VNDA has more cash than debt.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
VNDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.3 | Neutral |
| Stochastic | 11.2 | Oversold |
VNDA's weekly RSI is 31 (neutral) and its Stochastic is 11 (oversold).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
VNDA PE vs Healthcare Sector
| Metric | VNDA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
VNDA has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over VNDA on trend strength, trading above more of its moving averages.
VNDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.23 | 6.6% below |
| 20 week MA | $4.92 | 20% below |
| 50 week MA | $6.12 | 35% below |
| 100 week MA | $5.37 | 26% below |
| 200 week MA | $5.32 | 26% below |
VNDA is in a downtrend: it's below all five of its weekly moving averages, and 26% below its 200-week average.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over VNDA on returns for 2026, with the stronger performance.
VNDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.8 | $13.3 | -21% |
| 2021 | $13.3 | $18.0 | +35% |
| 2022 | $18.0 | $6.87 | -62% |
| 2023 | $6.87 | $4.22 | -39% |
| 2024 | $4.22 | $4.81 | +14% |
| 2025 | $4.81 | $7.04 | +46% |
| 2026 YTD | $7.04 | $3.95 | -44% |
VNDA has finished lower in three of the last six years. It's down 44% so far in 2026.